Bio-Rad Laboratories, Inc. (BIO.B) vs Smith & Nephew SNATS, Inc. (SNN)
- Bio-Rad Laboratories, Inc. BIO.B 364.15 −0.25%
- Smith & Nephew SNATS, Inc. SNN 29.06 −0.10%
Bio-Rad Laboratories, Inc. and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $12.2B against $10.3B — 1.2× the size. Smith & Nephew SNATS, Inc. trades at the lower P/E: 35.4× against 43.7×. Smith & Nephew SNATS, Inc. grew revenue faster over the last twelve months: 4.81% against 1.37%. Bio-Rad Laboratories, Inc. has the higher net margin (8.59% vs 6.71%) and the higher return on invested capital (0.49% vs 0.00%). Across the 22 metrics below, Bio-Rad Laboratories, Inc. leads on 11 and Smith & Nephew SNATS, Inc. on 11.
Valuation
Profitability
| Metric | BIO.B | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 70.52% | 56.01% |
| Operating margin | 2.05% | 0.00% | (15.03%) |
| Net margin | 8.59% | 6.71% | (20.40%) |
| Free cash flow margin | 13.64% | 0.00% | (7.24%) |
| Return on equity | 3.11% | 0.00% | (15.32%) |
| Return on assets | 2.17% | 0.00% | (19.72%) |
| Return on invested capital | 0.49% | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack